Research Article
A Prospective Evaluation of Two Rapid Phenotypical Antimicrobial Susceptibility Technologies for the Diagnostic Stewardship of Sepsis
Table 6
AST results of Alfred 60AST compared to Pheno. The summary of discrepancies and AST agreement in percent is reported in brackets (%).
(a) |
| | Antimicrobial agent | Number of discrepancies (%) | AST agreement (%) | Total |
| | Gram-positives | | | | | Ampicillin | 0/3 | 3/3 (100.0) | 3 | | Daptomycin | 0/4 | 4/4 (100.0) | 4 | | Linezolid | 0/6 | 6/6 (100.0) | 6 | | Vancomycin | 1/5 (20.0) | 4/5 (80.0) | 5 | | Cefoxitin | 0/2 | 2/2 (100.0) | 2 | | Clindamycin | 0/1 | 1/1 (100.0) | 1 | | Total | 1/21 (4.8) | 20/21 (95.2) | 21 |
|
|
(b) |
| | Antimicrobial agent | Number of discrepancies (%) | AST agreement (%) | Total |
| | Gram-negatives | | | | | Piperacillin/tazobactam | 11/40 (27.5) | 29/40 (72.5) | 40 | | Ceftazidime | 4/41 (9.8) | 37/41 (90.2) | 41 | | Ceftriaxone | 3/39 (7.7) | 36/39 (92.3) | 39 | | Cefotaxime | 0/1 | 1/1 (100.0) | 1 | | Meropenem | 7/41 (17.1) | 34/41 (82.9) | 41 | | Gentamicin | 6/40 (15.0) | 34/40 (85.0) | 40 | | Colistin | 4/38 (10.5) | 34/38 (89.5) | 38 | | Total | 35/240 (14.6) | 205/240 (85.4) | 240 |
|
|
